|
Aug 2015
As of Aug 31, 2015
|
May 2015
As of May 31, 2015
|
Feb 2015
As of Feb 28, 2015
|
Feb 2016
As of Feb 29, 2016
|
May 2016
As of May 31, 2016
|
Nov 2016
As of Nov 30, 2016
|
Feb 2017
As of Feb 28, 2017
|
Nov 2015
As of Nov 30, 2015
|
Aug 2016
As of Aug 31, 2016
|
Nov 2014
As of Nov 30, 2014
|
Aug 2014
As of Aug 31, 2014
|
May 2014
As of May 31, 2014
|
Feb 2014
As of Feb 28, 2014
|
Nov 2013
As of Nov 30, 2013
|
Aug 2013
As of Aug 31, 2013
|
May 2013
As of May 31, 2013
|
Feb 2013
As of Feb 28, 2013
|
Nov 2012
As of Nov 30, 2012
|
Aug 2012
As of Aug 31, 2012
|
Feb 2012
As of Feb 29, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Cash Overdraft | ||||||||||||||||||||
| Accrued Interest | ||||||||||||||||||||
| Accounts Payable & Accrued Expenses | ||||||||||||||||||||
| Loans Payable | ||||||||||||||||||||
| Loan Payable | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Stockholders' Equity: | ||||||||||||||||||||
| Common Stock, par value $0.001, 1.2 billion authorized shares issued and outstanding 175,187,683 respectively | ||||||||||||||||||||
| Additional Paid in Capital | ||||||||||||||||||||
| Common Stock to be Issued | ||||||||||||||||||||
| Retained Deficit | ||||||||||||||||||||
| Deficit Accumulated During the Development Stage | ||||||||||||||||||||
| Deficit Accumulated During Development Stage | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||||||
Loading...
